DE69607963D1 - Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit - Google Patents

Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit

Info

Publication number
DE69607963D1
DE69607963D1 DE69607963T DE69607963T DE69607963D1 DE 69607963 D1 DE69607963 D1 DE 69607963D1 DE 69607963 T DE69607963 T DE 69607963T DE 69607963 T DE69607963 T DE 69607963T DE 69607963 D1 DE69607963 D1 DE 69607963D1
Authority
DE
Germany
Prior art keywords
polymerized
hydroxyapatite
separation
hemoglobin
polymerized hemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69607963T
Other languages
English (en)
Other versions
DE69607963T2 (de
Inventor
E Wertz
S Gawryl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biopure Corp
Original Assignee
Biopure Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopure Corp filed Critical Biopure Corp
Publication of DE69607963D1 publication Critical patent/DE69607963D1/de
Application granted granted Critical
Publication of DE69607963T2 publication Critical patent/DE69607963T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69607963T 1995-06-07 1996-06-05 Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit Expired - Lifetime DE69607963T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,899 US5691453A (en) 1995-06-07 1995-06-07 Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC
PCT/US1996/009063 WO1996040782A1 (en) 1995-06-07 1996-06-05 Separation of hemoglobin on hydroxyapatite using hplc

Publications (2)

Publication Number Publication Date
DE69607963D1 true DE69607963D1 (de) 2000-05-31
DE69607963T2 DE69607963T2 (de) 2000-08-17

Family

ID=23889631

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69607963T Expired - Lifetime DE69607963T2 (de) 1995-06-07 1996-06-05 Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit

Country Status (9)

Country Link
US (1) US5691453A (de)
EP (1) EP0832130B1 (de)
JP (1) JPH11508236A (de)
AT (1) ATE192165T1 (de)
AU (1) AU6048496A (de)
CA (1) CA2222755C (de)
DE (1) DE69607963T2 (de)
ES (1) ES2145456T3 (de)
WO (1) WO1996040782A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804551A (en) * 1996-11-12 1998-09-08 Baxter International Inc. Pretraumatic use of hemoglobin
US6500809B1 (en) 1999-11-12 2002-12-31 Neuron Therapeutics, Inc. Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
US6680376B2 (en) * 2000-12-08 2004-01-20 Good Biotech Corporation Process for selectively isolating avian immunoglobulins
US6518010B2 (en) 2001-02-28 2003-02-11 Biopure Corporation Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
CA2444590C (en) 2001-04-18 2009-12-01 Robert L. Mcginnis Stabilized hemoglobin solutions
US7001715B2 (en) * 2002-02-28 2006-02-21 Biopure Corporation Purification of red blood cells by separation and diafiltration
WO2003074077A1 (en) 2002-02-28 2003-09-12 Biopure Corporation Purification of red blood cells by separation and diafiltration
US7008620B2 (en) * 2002-09-30 2006-03-07 Johnson & Johnson Consumer Companies, Inc. Depilatory compositions and articles and the use thereof
CN1703235A (zh) * 2002-10-03 2005-11-30 北原实验室有限公司 治疗大量失血患者的方法
BRPI0407106A (pt) * 2003-01-29 2006-01-24 Northfield Lab Soluções de hemoglobina polimerizadas com quantidade reduzida de tetrâmero e método para preparação
WO2006108047A2 (en) * 2005-04-05 2006-10-12 Biopure Corporation Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization
US20090117207A1 (en) * 2005-11-29 2009-05-07 Zoltani Csaba K Methods and compositions for treatment of poison-caused pathology
WO2007087570A2 (en) 2006-01-24 2007-08-02 Northfield Laboratories, Inc. Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
JP5260967B2 (ja) * 2006-02-09 2013-08-14 アークレイ株式会社 液体クロマトグラフィ装置
JP5927634B2 (ja) 2010-03-19 2016-06-01 インサイシヴ テクノロジーズ プロプライエタリー リミテッド 多孔質歯科ハイドロキシアパタイトを検出するためのキットおよび方法
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
CN102284276B (zh) * 2011-06-28 2013-01-02 淮阴工学院 由废白土制备复合吸附剂的方法
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
WO2019018403A1 (en) 2017-07-18 2019-01-24 Virtech Bio, Llc BLOOD SUBSTITUTES COMPRISING HEMOGLOBIN AND METHODS OF MAKING
CN111989568A (zh) * 2018-04-18 2020-11-24 积水医疗株式会社 血红蛋白分析方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32089E (en) * 1970-08-25 1986-03-04 Amicon Corporation Blood fractionating process and apparatus for carrying out same
DE2248475C3 (de) * 1972-10-03 1978-09-28 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Gewinnung von hepatitissicheren, lagerungsstabilen und infundierbaren Hämoglobinlösungen
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US3944391A (en) * 1974-12-27 1976-03-16 Preventive Systems, Inc. In vitro process for detecting endotoxin in a biological fluid
US4059512A (en) * 1974-12-27 1977-11-22 Preventive Systems, Inc. Process for removing endotoxin from biological fluids
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4136093A (en) * 1976-04-23 1979-01-23 Biotest-Serum-Institut Gmbh Hemoglobin preparation with increased oxygen release
US4376059A (en) * 1980-04-11 1983-03-08 Exxon Research And Engineering Co. Process for preparing artificial red cells
DK144800C (da) * 1980-04-21 1982-10-25 Forenede Bryggerier As Fremgangsmaade til udvinding af enzymer,fortrinsvis cu,zn-superoxid-dismutase (sod),catalase og carbonsyreanhydrase,fra blod
US4468330A (en) * 1981-04-27 1984-08-28 Sekisui Kagaku Kogyo Kabushiki Kaisha Filler for liquid chromatography useful for separating a hemoglobin variant in blood
DE3130770C2 (de) * 1981-08-04 1986-06-19 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Gewinnung von hepatitissicheren, sterilen, pyrogenfreien und stromafreien Hämoglobinlösungen
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
CA1244349A (en) * 1985-06-26 1988-11-08 Jen-Chang Hsia Purification of hemoglobin and modified hemoglobin by affinity chromatography
GB8600582D0 (en) * 1986-01-10 1986-02-19 Ca Minister Nat Defence Purifying biological materials
US5194590A (en) * 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
DE3636590A1 (de) * 1986-10-28 1988-05-26 Braun Melsungen Ag Blutersatzmittel
EP0277289B8 (de) * 1986-11-10 2003-05-21 Biopure Corporation Hochreines, halbsynthetisches Blutsurrogat
CA1312009C (en) * 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4861867A (en) * 1988-02-03 1989-08-29 Baxter International, Inc. Purified hemoglobin solutions and method for making same
JPH0743358B2 (ja) * 1988-05-16 1995-05-15 三井東圧化学株式会社 液体クロマトグラフィー用充填材及びカラム
CA1338244C (en) * 1988-08-17 1996-04-09 Xiang-Fu Wu Purification of hemoglobin and methemoglobin by bioselective elution
US5250665A (en) * 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion

Also Published As

Publication number Publication date
JPH11508236A (ja) 1999-07-21
DE69607963T2 (de) 2000-08-17
ATE192165T1 (de) 2000-05-15
CA2222755C (en) 2008-05-20
US5691453A (en) 1997-11-25
AU6048496A (en) 1996-12-30
EP0832130B1 (de) 2000-04-26
WO1996040782A1 (en) 1996-12-19
CA2222755A1 (en) 1996-12-19
EP0832130A1 (de) 1998-04-01
ES2145456T3 (es) 2000-07-01

Similar Documents

Publication Publication Date Title
DE69607963D1 (de) Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit
DE68922427T2 (de) Verfahren zur Zurückgewinnung von sauerstoffreichem Gas.
ATE329045T1 (de) Verfahren zur aufreinigung von rekombinanten, viralen vektoren welche ein therapeutisches gen enthalten
ATE326476T1 (de) Verfahren zur herstellung von phosphorothioat- oligomeren
HK1008731A1 (en) Antibody for the treatment of insulin dependent diabetes
DE68909124D1 (de) Verwendung von Polyimides als Trennmembranen.
DE69106815T2 (de) Verfahren zur Herstellung von veränderten Kohlenstoffmolekularsieben zur Gastrennung.
NO885275L (no) Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav.
DK447489A (da) Metode til stabilisering af blod
FR2712821B1 (fr) Procédé et installation de fourniture d'azote au moyen de membranes semi-perméables utilisant une géométrie membranaire variable.
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DK0641861T3 (da) Fremgangsmåde til fremstilling af hydrofobe polypeptider, proteiner eller peptider
GB2218991B (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
DK398987D0 (da) Fremgangsmaade til fremstilling af blodprotein
BG102064A (en) Method for increasing the retinal blood circulation
DE68918083D1 (de) Verfahren zur reinigung von blutplasma.
DE69023732D1 (de) Blutplasmatrennmembran und Blutplasmaseparator unter Verwendung einer solchen Membran.
ATE212349T1 (de) Neues verfahren zur herstellung von nucleosiden
HUT55800A (en) Process for producing anticoagulant peptides
OA09384A (fr) "Système matriciel autoadhésif pour la libération prolongée du piribédil par voie transcutanée".
DE69006489D1 (de) Verfahren zur kontinuierlichen wiedergewinnung von fluorwasserstoffgas.
DE69328060T2 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
DE68915387D1 (de) Verfahren zur Herstellung von ethylenischen Pfropfcopolymeren.
DE59309127D1 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen
DE68906251T2 (de) Verfahren zur herstellung von addukten von butadienoligomeren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition